title: Looking Deep Into the Heterogeneity of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Can We Understand It Better?
authors.affiliation: Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia sherene.loi@petermac.org.
authors.forename: Sherene
authors.initials: S
authors.lastname: Loi
authors.affiliation: Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Savas
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D002277:Carcinoma / Q000737:chemistry* / Q000188:drug therapy*; D005260:Female; D015870:Gene Expression; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases